Profund Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,663
| Closed | -$389K | – | 1165 |
|
|
2022
Q4 | $389K | Buy |
10,663
+300
| +3% | +$10.9K | 0.03% | 514 |
|
|
2022
Q3 | $295K | Sell |
10,363
-369
| -3% | -$10.5K | 0.02% | 598 |
|
|
2022
Q2 | $486K | Sell |
10,732
-678
| -6% | -$30.7K | 0.03% | 421 |
|
|
2022
Q1 | $868K | Sell |
11,410
-1,181
| -9% | -$89.8K | 0.04% | 357 |
|
|
2021
Q4 | $1.88M | Sell |
12,591
-2,100
| -14% | -$313K | 0.06% | 216 |
|
|
2021
Q3 | $2.14M | Buy |
14,691
+2,032
| +16% | +$296K | 0.07% | 218 |
|
|
2021
Q2 | $2.48M | Sell |
12,659
-228
| -2% | -$44.6K | 0.08% | 193 |
|
|
2021
Q1 | $2.33M | Sell |
12,887
-997
| -7% | -$180K | 0.09% | 183 |
|
|
2020
Q4 | $1.97M | Buy |
13,884
+2,620
| +23% | +$371K | 0.09% | 197 |
|
|
2020
Q3 | $1.4M | Buy |
11,264
+8,696
| +339% | +$1.08M | 0.07% | 223 |
|
|
2020
Q2 | $229K | Buy |
+2,568
| New | +$229K | 0.01% | 750 |
|